INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Data sources
SEC FORM 453m ago
HOUSE PTR52m ago
SEC 13F52m ago
ROBINHOOD CHAIN52m ago
RE
Corporate insider

Rote William E.

Chief Research OfficerCIK 0001698262

EDGAR filingsOpen in network
Disclosed transactions5
Buys / sells0 / 2
Max Insider Score43
Connections with evidence1

Disclosed transactions

ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
26
RE
Rote William E.Chief Research Officer
TVTXTravere Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$356K
9,100 sh
Apr 22, 2026Apr 23, 2026
traded Apr 22, 2026
+1dSEC FORM 4

Evidence

Verified connections

  • Insider ofevidence
    Travere Therapeutics, Inc.Chief Research Officer · Dec 29, 2025
0
RE
Rote William E.Chief Research Officer
TVTXTravere Therapeutics, Inc.
Grant or award · 10b5-1 plan
A
—
14.0K sh
Apr 13, 2026
Apr 15, 2026
traded Apr 13, 2026
+2d
SEC FORM 4

Evidence

5
RE
Rote William E.Chief Research Officer
TVTXTravere Therapeutics, Inc.
Option exercise · 10b5-1 plan
M—
60.0K sh
Dec 24, 2025Dec 29, 2025
traded Dec 24, 2025
+5dSEC FORM 4

Evidence

26
RE
Rote William E.Chief Research Officer
TVTXTravere Therapeutics, Inc.
Option exercise · 10b5-1 plan
M$1.24M
60.0K sh
Dec 24, 2025Dec 29, 2025
traded Dec 24, 2025
+5dSEC FORM 4

Evidence

43
RE
Rote William E.Chief Research Officer
TVTXTravere Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$2.41M
60.0K sh
Dec 24, 2025Dec 29, 2025
traded Dec 24, 2025
+5dSEC FORM 4

Evidence